ClinicalTrials.gg
Active, not recruitingNCT06657807Updated May 14, 2026

Online Cognitive Behavior Therapy for Anxiety Related to Pediatric Asthma

An interventional study of Online CBT in Asthma and Anxiety, sponsored by Karolinska Institutet. Active, not recruiting at 1 site in Sweden. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
8 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Asthma by Karolinska Institutet — 2 open to participants now, 5 under way, none of them phase 3. Asthma · Karolinska Institutet.

Planned enrollment
11th of 14
30 · median 50
Started
2024
the only one that year
No phase
12 of 15
1 open now
Registered
12th of 15
by date

Among the 15 studies in Asthma by Karolinska Institutet, this one is the 11th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2024, is one of 12 with no phase, and was the 12th registered.

Asthma

4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.

Browse Asthma studies →

Open to participants now

2 of the 15 studies in Asthma by Karolinska Institutet are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.

This study: 8 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Asthma by Karolinska Institutet, or all of them as a file.
02

Study summary

Asthma is a chronic condition affecting approximately 5-15% of all Swedish children. Research has shown that asthma may be associated with increased anxiety and worry, with children who have asthma being twice as likely to experience anxiety compared to those without asthma. The coexistence of anxiety and asthma can worsen asthma symptoms and heighten anxiety, as it can be challenging to distinguish between the two conditions. Cognitive behavioral therapy (CBT) is a recommended treatment for anxiety in children, but few studies have examined the effectiveness of CBT in children with both asthma and anxiety. Our research group has previously developed internet-delivered CBT (Internet-CBT) targeting anxiety in asthma for adults, yielding promising results. Internet-CBT can significantly improve access to treatment and has been shown to be both effective and safe for other medical conditions.

The primary aim of this project is to investigate whether Internet-CBT can contribute to improved quality of life, better asthma control, and reduced anxiety in children and adolescents whose asthma is complicated by their own or their parents' anxiety. We have previously developed Internet-CBT for adults with asthma and anxiety with promising outcomes. For this study, we have adapted the treatment for children, adolescents, and their parents and will evaluate its feasibility and clinical effectiveness.

Read the detailed description

This study will use an uncontrolled pretest-posttest design, all participants will receive the intervention. The intervention consists of 8 weekly modules delivered over internet with guided support from an experienced CBT-trained psychologist.

Assessments will be made pretreatment, weekly during treatment for the primary outcome and potential mediators, posttreatment, at the primary endpoint 2 months after treatment completion and at follow up 6 months after treatment completion. Thirty participants (aged 8-17 years) will be included. All outcome data will be collected digitally and include for feasibility: treatment credibility, working alliance, compliance with the treatment (number of modules completed) and with asthma medications as prescribed by the child´s physician, any adverse events, subjective overall relief and satisfaction with treatment. For potential efficacy, the clinical effect in the group will be analyzed on pre- to post-measurements, including weekly measurements and 2 months follow up after treatment termination (primary endpoint). The participants will be followed 6 months after treatment completion to analyze longer term clinical effects.

Recruitment and inclusion procedure Participants will be self-recruited through advertisements in social media and posters at pediatric health care clinics. Potential participants will undergo an online self-report screening of eligible criteria. The parents and adolescents 15 and older, will receive digital information about the study and leave their written consent online. The screening will be followed by an evaluation with a clinical psychologist using a structured interview based on the DSM diagnostic. During the clinical interview, the children (>age 15) will receive information about the study and leave their informed consent orally. The families will have the opportunity to ask questions about the study and confirm previous written consent.

After inclusion, participants may start their treatment immediately.

03

Conditions studied

  • Asthma
  • Anxiety

Keywords

  • Internet-CBT
  • Adolescent
  • Children
  • Parents
04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 8-17 years
  • A diagnosis of asthma made by a physician and confirmed by the parents
  • Some anxiety related to asthma reported by either parent of child ("Do you feel stressed or worried about your asthma?" yes/no) and/or some restriction by asthma in daily life, which could indicate a pattern of avoidance behavior ("Do you feel hindered by your asthma in your daily life?" yes/no)

Exclusion criteria

Exclusion Criteria:

  • Presence of severe psychiatric disorders such as severe depression or suicidal ideation.
  • Concurrent psychological treatment
  • Presence of severe somatic disorder that could interfere with participation in the CBT-treatment
  • Other respiratory disease than asthma
  • Psychotropic medication should be stable for at least 1 month before entering the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Internet-CBT

    Internet-CBT including 8 weekly modules

    Behavioral: Online CBT

Interventions

  • BehavioralOnline CBT

    Online CBT targeting anxiety in pediatric asthma

    Also known as: Internet-CBT, Internet-delivered cognitive behavior therapy

06

What researchers measure

Primary outcomes

  1. PedsQL Asthma Module

    Questionnarie about asthma symptoms. Participants report how much of a problem asthma have been for them the past month on a scale ranging from 0 (never) to 5 (almost always).

    Time frame: From pretreatment to 16 weeks

Secondary outcomes

  1. PedsQL Quality of Life Inventory

    Questionnaire about Quality of Life. Participants report how much of a problem they/their child has with psychical, emotional, social and study functioning for them the past month on a scale ranging from 0 (never) to 5 (almost always).

    Time frame: From pretreatment to 16 weeks

  2. Asthma Control Test

    Asthma Severity

    Time frame: From pretreatment to 16 weeks

  3. Asthma Behavior Checklist

    Avoidance behavior due to fear of asthma

    Time frame: From pretreatment to 16 weeks

  4. Fear of Asthma Symptoms Scale

    Fear of bodily symptoms of Asthma. Questionnaire where the scale ranges from 0 (never) to 5 (always). A higher score means worse outcome.

    Time frame: From pretreatment to 16 weeks

  5. Youth Asthma Related Anxiety Scale

    Anxiety related to asthma. Questionnaire where the scale ranges from 0 (never) to 5 (always). A higher score means worse outcome.

    Time frame: From pretreatment to 16 weeks

  6. Subjective Adequate Relief Questionnaire

    Subjective Adequate Relief Questionnaire measures self-perceived change in symptoms as a result of the treatment. The scale consists of 2 items rated from 0 (much worse) to 6 (much better).

    Time frame: Week 8

  7. Client Satisfaction Questionnaire

    Time frame: Week 8

  8. Working Alliance Inventory

    Questionnaire used to assess perceived alliance with the online therapist. The questions are scored on a scale from 1 (never) to 7 (always). A higher score means better outcome.

    Time frame: Week 3

  9. Credibility Rating Scale

    The Credibility Scale was developed to assess the participant's expectations of the treatment. The scale ranges from 0 (not at all) to 10 (very much). A higher score means better outcome.

    Time frame: Week 2

  10. Adverse events

    Time frame: Week 8

  11. Spence Children's Anxiety Scale

    Spence Children's Anxiety Scale is used to assess symptoms of anxiety and is specifically developed for children. The scale ranges from never (0) to always (3). A higher score means worse outcome.

    Time frame: From pretreatment to 16 weeks

  12. Child Depression Inventory

    Time frame: From pretreatment to 16 weeks

  13. Adult responses to children's symptoms

    Questionnaire used to assess how parents respond to their children when they have symptoms. The questions are scored on a scale from 0 (never) to 4 (always). A higher score means worse outcome.

    Time frame: From pretreatment to 16 weeks

07

Study locations

1 site
  • Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care
    Stockholm, Sweden
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.

Of 601 non-industry interventional studies with no phase under Asthma, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's planned 24 months is close to that.

Counting every sponsor, half of 651 studies reached it within 23 months; a quarter within 10 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2024
First posted
Oct 24, 2024
StartActual
Dec 1, 2024
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
May 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06657807
Responsible party
Marianne Bonnert (Principal Investigator, Karolinska Institutet) — Principal investigator
First posted
Oct 24, 2024
Start date
Dec 1, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion